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Abstract 
 
Background: Dimethyl sulfoxide (DMSO) is 
commonly used as a solvent for anti-fungal drugs. It has 
been reported to possess anti-fungal activity by itself so 
may interfere in the evaluation and comparison of anti-
fungal drugs. DMSO 1% and below are usually considered 
to possess insignificant effect on the growth of fungi. The 
present study was aimed to determine any 
additive/synergistic effect of DMSO (1%) with anti-fungal 
drugs.  
 
Methods: The effect of DMSO (1%) was determined on 
the colonial growth of Trichophyton rubrum, and 
Microsporum canis along with clotrimazole, griseofulvin, 
ketoconazole and thymoquinone (an active principle of 
Nigella sativa). Similarly, the ability of DMSO (1%) to 
enhance the effect of amphotericin-B and thymoquinone 
was observed on the growth of Aspergillus niger. The fungi 
were grown in three sets of plates of dermasel agar for 
each drug containing: (a) serial dilutions of the drug alone; 
(b) serial dilutions of the drug plus DMSO 1% in each 
dilution and (c) dermasel agar alone, as control.  
 
Results: DMSO (1%) lowered the MICs of all drugs 
tested against the fungi used, except amphotericin-B 
against Aspergillus niger. Presence of DMSO (1%) in serial 
dilutions of drugs also significantly shifted the growth 
curves of fungi towards right.  
 
Conclusion: DMSO, as a solvent, is one of the 
important factors that can alter the results of antifungal 
drugs.  
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Introduction 
 
Dimethyl Sulfoxide (DMSO) is frequently used 
as a solvent for antifungal drugs in various studies for 
the determination of their MICs1-5. The stock solutions 
of anti-fungal drugs are usually prepared in 100% 
DMSO and then serial dilutions are made in the 
culture media, which changes the concentration of 
DMSO from higher to lower, in different sets of plates 
or tubes.  
The influence of various concentrations of 
DMSO (2, 1 and 0.5%) on the growth of yeast (Candida 
species) has been investigated in one study, reporting 
that 2% DMSO significantly slowed the growth and 
lowered the growth curve in all 8 species of Candida 
tested while 1% and below had insignificant effect on 
the kinetics of growth6. Therefore, DMSO 1% and 
below are usually considered as safe. However, 
recently, we have reported the inhibitory effect of 
DMSO on the growth of some dermatophytes even 
below 1%7.  
The present study was aimed to investigate 
how far DMSO 1% could affect the activity of 
antifungal drugs in terms of alterations in their MICs 
and overall growth in their serial dilutions.  
 
Materials and Methods 
 
a. Source of DMSO, drugs and dermasel agar: 
DMSO, clotrimazole, griseofulvin, 
ampotericin-B and thymoquinone were obtained from 
SIGMA-USA and ketoconazole from Spectrum 
Chemical Manufacturing Corporation USA. The 
dermasel agar (containing mycological peptone 1%, 
glucose 2% and agar 1.45%) and dermasel agar with a 
supplement of chloramphenicol and cycloheximide 
were obtained from OXOID, England.  
b. Fungi 
Trichophyton rubrum and Microsporum canis 
were obtained from skin scrapings of patients with 
clinical diagnosis of dermatophytosis. They were 
initially inoculated on dermasel agar with a 
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supplement of chloramphenicol and cycloheximide, incubated  at 30O  C  for  7-10  days  and  identified by  
Table 1.  Percentage inhibition of the growth of T. rubrum and M. canis by various 
concentrations of clotrimazole, ketoconazole, griseofulvin and thymoquinone on day 14, 
alone and in the presence of DMSO 1%. 
a. T. rubrum 
Clotrimazole 
 
(µg//ml) 5 2.5 1.25 0.62 0.31 0.15 0.07  
Alone 100 91.6 87.4 85.2 77.1 63.3 50.6  
With DMSO 1% 100 100 92.2 88.6 82.8 74.4 63  
Griseofulvin 
 
µg/ml 10 5 2.5 1.25 0.62 0.31 0.15 0.075 
Alone 82.4 69.3 63.5 58.1 51.4 44 31.6 21 
With DMSO 1% 89.1 81.2 70.8 66.6 62.3 57.8 49.8 39.8 
Ketoconazole 
 
 
(µg/ml) 10 5 2.5 1.25 0.62 0.31 0.15 0.075 
Alone 81.9 76.5 69.4 59.5 53.3 36.9 24.4 9.5 
With DMSO 1% 86.9 80.9 75.9 67.9 61.9 54.8 45.3 37.8 
Thymoquinone 
 
mg/ml 0.2 0.1 0.05 0.025 0.012    
Alone 100 46.5 22.6 14.4 9.1    
With DMSO 1% 100 100 59.3 37.9 23    
b. M. canis 
Clotrimazole 
 
(µg//ml) 0.62 0.31 0.15 0.075 0.037 0.018 0.009  
Alone 84.8 75.8 64.8 45.9 31.6 20.9 13.52  
With DMSO 1% 100 82.4 75.8 57.4 40.2 26.6 19.3  
Griseofulvin 
 
µg/ml 10 5 2.5 1.25 0.62 0.31 0.15  
Alone 100 81.3 79.8 76.7 71.8 64.5 57.3  
With DMSO 1% 100 100 84 80.9 76.7 72.5 63  
Ketoconazole 
 
 
(µg/ml) 4 2 1 0.5 0.25 0.125 0.062 0.031 
Alone 80.5 66.9 51.9 39.1 31.2 25.6 22.6 18.8 
With DMSO 1% 87.2 80.8 65 50.8 38 35 33.9 32.7 
Thymoquinon
e 
 
mg/ml 0.25 0.125 0.062 0.031 0.15    
Alone 100 100 30 4.4 0.9    
With DMSO 1% 100 100 100 33.5 25.6    
 
their colonial morphology and microscopic 
examination of lactophenol cotton blue mounts from 
the colonies. Subcultures were then prepared on 
dermasel agar plates for 7-10 days for use in the 
experiment.  
Standard strains of Aspergillus niger were 
obtained from UK, initially inoculated on dermasel 
agar with a supplement of chloramphenicol and 
cycloheximide and then sub-cultured on dermasel 
agar plates for 3-4 days. 
c. Preparation of dilutions of drugs 
Stock solutions of antifungal drugs were 
prepared in a solvent other than DMSO (alcohol) and 
serial dilutions made in the dermasel agar in two sets: 
(a) without DMSO and (b) containing 1% DMSO in 
each dilution.  
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d. Antifungal susceptibility test 
The isolates of various fungi were sub-
cultured on three set of culture media containing: Set 
(a) serial dilutions of drug in dermasel agar; Set (b) 
serial dilutions of drug and 1% DMSO and Set (c) 
dermasel agar only (controls). Four plates were used 
for each dilution and the controls. 
Colonial discs of 5 mm in diameter were cut 
from the periphery of 7-10 days old cultures of 
dermatophytes, as well as from 3-5 days old cultures 
of Aspergillus in dermasel agar, aseptically inoculated 
onto different sets of media and then incubated at  
30O C. The cultures were examined on day 2nd and 4th 
for Aspergillus and day 7th and 14th for 
dermatophytes. Diameter of the growth of fungi was 
measured in each plate and the results of day 4th for 
Aspergillus and day 14th for dermatophytes were 
interpreted by the measurement of the mean of four 
plates at each level of dilution8.  
e. Analysis of results:  
From the mean growth of fungus at each 
concentration level of the drug, percentage inhibition 
of the growth was determined in the absence as well 
as in the presence of DMSO1%, taking that of controls 
as 100%. MIC of each drug tested was taken as the 
concentration causing more than 80% inhibition. 
Linear graphs were plotted taking concentration of the 
drug in the X-axis and mean growth in the Y-axis, for 
both in the absence as well presence of DMSO 1%.  
 
Results: 
 
The percentage inhibition of the growth of T.  
rubrum and M. canis with clotrimazole, ketoconazole, 
griseofulvin and thymoquinone alone and in the 
presence of DMSO 1% is given in Table 1 and that of 
A. niger with amphotericin-B and thymoqunone in 
Table 2. There was a dose related inhibitory effect on 
the growth of fungi by all drugs tested. 
 
Table 2. Percentage inhibition of growth of A. niger by various concentrations of 
amphotericin-B and thymoquinone on day 4; alone and in the presence of DMSO 1%. 
Ampotericin B  
 
(mg/ml) 1 0.5 0.25 0.125 0.062 0.031 0.015 
Alone 73.8 70.9 68.7 64.1 58.2 51.9 42.6 
With DMSO1% 76.3 74.3 68.4 63.7 57.8 52.3 45.6 
Thymoquinone 
  
(mg/ml) 1 0.5 0.25 0.125 0.062 0.031 0.015 
Alone 100 87.9 62.7 52.7 46.6 34.2 9.3 
With DMSO1% 100 100 73.9 59.4 50.9 42.5 34.2 
 
Table 3. MIC of various antifungal drugs alone and in the presence of DMSO 1% against T. 
rubrum, M. canis and A. niger. 
a. T. rubrum and  M. canis 
  T. rubrum M. canis 
Alone  With DMSO 1% Alone  With DMSO 1% 
Clotrimazole 1.25 0.31 0.62 0.31 
Griseofulvin 10 5 0.31 0.075 
Ketoconazole 10 5 4 2 
Thymoquinone* 2 1 0.25 0.062 
* (mg/ml) 
b. A. niger 
Drug (mg/ml) Alone  With DMSO 1% 
Amphotericin-B 74%  inhibition with  1 mg/ml 74%  inhibition with   0.5 mg/ml 
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Thymoquinone 1 0.5 
 
MICs of clotrimazole, griseofulvin, 
ketoconazole and thymoquinone against T. rubrum in 
the absence of DMSO were 1.25µg/ml, 10µg/ml, 
10µg/ml and 2mg/ml; while in the presence of DMSO 
1% MICs were 0.31µg/ml, 5µg/ml, 5µg/ml and 
1mg/ml, respectively. Similarly MICs of clotrimazole, 
griseofulvin, ketoconazole and thymoquinone against 
M. canis in the absence of DMSO were 0.62µg/ml, 
0.31µg/ml, 4µg/ml and 0.25mg/ml; while in the 
presence of DMSO 1% were 0.31µg/ml, 0.075µg/ml, 
2µg/ml and 0.062mg/ml, respectively (Table 3a).  
There was no change in the MIC of 
amphotericin-B with DMSO 1% while it reduced the 
MIC of thymoquinone from 1mg/ml to 0.5mg/ml 
(Table 3b).  
Linear graphs for the concentration of the 
drug versus growth, both in the absence as well 
presence of DMSO 1% are shown in figures 1 to 10. 
There was a consistent shift of the growth curves 
towards right with all drugs in the presence of DMSO 
1%, except amphotericin-B against A. niger. 
 
Discussion 
 
In the comparative evaluation poor agreement 
between methods for antifungal drug susceptibility 
testing has been reported9. One factor might be the 
effect of DMSO on the growth of fungi, commonly 
used as a solvent.  
 
Fig 1. Growth curves of T. rubrum in the presence of 
different concentrations of clotrimazole alone and 
the same concentrations of Clotrimazole plus DMSO 
1%. A shift towards right of the latter shows an 
additive effect of DMSO.  
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Fig 2. Growth curves of M. canis in the presence of 
different concentrations of clotrimazole alone and 
the same concentrations of clotrimazole plus DMSO 
1%. A shift towards right of the latter shows an 
additive effect of DMSO.  
0
20
40
60
1 2 3 4 5 6 7
Clotrimazole (µg/ml)
G
ro
w
th
  (
m
m
)
Clotrimazole alone
Clotrimazole & DMSO (1%)
 
Fig 3. Growth curves of T. rubrum in the presence of 
different concentrations of griseofulvin alone and 
the same concentrations of griseofulvin plus DMSO 
1%. A shift towards right of the latter shows an 
0.62   0.31   0.15  0.075  0.037   0.018   0.009 
5  2.5 1.25  0.62   0.31    0.15  0.07 
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additive effect of DMSO.  
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Fig 4. Growth curves of M. canis in the presence of 
different concentrations of griseofulvin alone and 
the same concentrations of grseofulvin plus DMSO 
1%. A shift towards right of the latter shows an 
additive effect of DMSO.  
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Fig 5. Growth curves of T. rubrum in the presence of 
different concentrations of ketoconazole alone and 
the same concentrations of ketoconazole plus DMSO 
1%. A shift towards right of the latter shows an 
additive effect of DMSO.  
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Fig 6. Growth curves of M. canis in the presence of 
different concentrations of ketoconazole and the 
same concentrations of ketoconazole plus DMSO 1%. 
A shift towards right of the latter shows an additive 
effect of DMSO.  
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Fig 7. Growth curves of T.rubrum in the presence of 
different concentrations of thymoquinone alone and 
the same concentrations of thymoquinone plus 
 10     5  2.5     1.25    0.62   0.31    0.15       0.075 
 10      5       2.5       1.25      0.62      0.31     0.15  
 10   5   2.5   1.25   0.62    0.31    0.15    0.075 
 4  2 1    0.5     0. 25   0.125  0.062  0.031 
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DMSO 1%. A shift towards right of the latter shows 
an additive effect of DMSO.  
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Fig 8. Growth curves of M. canis in the presence of 
different concentrations of thymoquinone alone and 
the same concentrations of thymoquinone plus 
DMSO 1%. A shift towards right of the latter shows 
an additive effect of DMSO.  
0
20
40
60
1 2 3 4
Thymoquinone (mg/ml)
G
ro
w
th
 (m
m
)
Thymoquinone alone
Thymoquinone & DMSO (1%)
 
 
Fig 9. Growth curves of A.  nigers in the presence of 
different concentrations of thymoquinone alone and 
the same concentrations of thymoquinone plus 
DMSO 1%. A shift towards right of the latter shows 
an additive effect of DMSO.  
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Fig 10. Growth curves of A. niger in the presence of 
different concentrations of amphotericin-B alone and 
the same concentrations of amphotetricin-B plus 
DMSO 1%.  
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In the present study DMSO 1% significantly 
decreased MICs of clotrimazole, griseofulvin, 
0. 25        0.125         0.062         0.031         0.015 
  0. 25      0.125             0.062             0.031 
  1         0.5       0.25     0.125    0.062    0.031   0.015 
1          0.5       0.25     0.125    0.062    0.031     0.015 
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ketoconazole and thymoquinone against T. 
mentagrophytes and M. canis. There was 
concentration dependant inhibition of the growth of 
fungi by these drugs and the presence of DMSO 1% 
shifted the concentration related growth curves of the 
fungi towards right, showing an additive effect with 
them. Thymoquinone, an active principle of N. sativa, 
has previously been shown to inhibit dermatophytes 
in a dose related fashion10.  
Azoles and griseofulvin are inactive against 
Aspergillus11-13, therefore, we used amphotericin-B, 
which is widely used against Aspergillus infection. 
Failure of amphotericin-B treatment against invasive 
aspergillosis has also been reported. Overall, the 
response to amphotericin B remains poor, with a 
favourable outcome in only 30–40% of treated 
patients14-15. We also observed higher MIC (1mg/ml 
showing only 74 % inhibition) of amphotericin-B 
against A. niger. Thymoquinone was used because in a 
previous study we found thymoquinone inhibits A. 
niger comparable to amphotericin-B16.  
 
Conclusions 
 
DMSO 1% causes an additive effect with 
antifungal drugs, can lower their MICs against 
dermatophytes and shifts their growth kinetics. 
Therefore, it is an important factor in the variability of 
results for the evaluation of antifungal drugs. 
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